SCHEMBL6926901

SCHEMBL6926901

O=C1c2ccccc2-c2ccncc21

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.95
MAOB P27338 1/20 0.95
CDC25B P30305 2/20 0.63
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
MAPT P10636 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
BLM P54132 3/20 0.52
PTPRC P08575 3/20 0.52
MAPK1 P28482 2/20 0.52
KDM4E B2RXH2 2/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
S100A4 P26447 2/20 0.52
HTT P42858 2/20 0.52
CES2 O00748 1/20 0.52
APAF1 O14727 1/20 0.52
TERT O14746 1/20 0.52
PLIN1 O60240 1/20 0.52
TDP2 O95551 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350676 0.98 MAOA (1.00) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL421291 0.98 MAOA (1.00) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL19013209 0.95 MAOA (0.87) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL3066734 0.95 MAOA (0.87) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL31112247 0.91 MAOA (0.77) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL20618218 0.91 MAOA (0.77) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL8417659 0.91 MAOA (0.86) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL30616365 0.91 MAOA (0.86) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL16685145 0.85 MAOA (0.70) MAOAMAOBCDC25BMEN1KMT2A
SCHEMBL9269089 0.85 MAOA (0.77) MAOAMAOBCDC25BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-53052428-A None JP disclosed
CN-111808023-B Method for preparing 3-aryl isoquinoline derivative 四川大学 2022-10-21 CN disclosed
CN-106831581-B Azaspiro-bifluorene derivative and preparation method thereof 上海大学 2021-07-09 CN disclosed
CN-110132915-B Aggregation-induced emission probe and method for dual detection of heavy metal ion pollutants 华南理工大学 2020-09-22 CN disclosed
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-10 US disclosed
US-6515011-B2 Anticoagulants MERCK & CO., INC. 2003-02-04 US disclosed
US-20020119992-A1 Thrombin inhibitors MERCK & CO., INC. 2002-08-29 US disclosed
WO-2002050056-A1 BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-06-27 WO disclosed
US-5434264-A α,α-disubstituted aromatics and heteroaromatics as cognition enhancers THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-07-18 US disclosed
WO-1994009002-A1 2-(AZA-9-FLUORENONYL)CARBAPENEM ANTIBACTERIAL AGENTS MERCK & CO., INC. (US) 1994-04-28 WO disclosed
US-4740602-A Indole derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-04-26 US disclosed
US-4717725-A SPIROCYCLIC AROMATIC IMIDES ALCON LABORATORIES, INC. (US) 1988-01-05 US disclosed
EP-0206225-A2 Indole derivatives MERCK PATENT GmbH (DE) 1986-12-30 EP disclosed
US-4537892-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1985-08-27 US disclosed
EP-0137333-A2 Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase ALCON LABORATORIES, INC. (US) 1985-04-17 EP disclosed
US-4446217-A Electrophotographic photosensitive member having a hydrazone containing layer CANON KABUSHIKI KAISHA (JP) 1984-05-01 US disclosed
US-4399208-A PHENYL HYDRAZONES CANON KABUSHIKI KAISHA (JP) 1983-08-16 US disclosed
JP-S5352428-A PHOTOCONDUCTIVE LIGHT SENSITIVE ELEMENT RICOH CO LTD 1978-05-12 JP disclosed
US-3984378-A PHOTOCONDUCTIVE FILMS KABUSHIKI KAISHA RICOH (JA) 1976-10-05 US disclosed
US-3974167-A (7-Nitro-2-aza-9-fluorenylidene) malononitrile RICOH CO., LTD. (JA) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLCO2A1, SLCO1A2 MAOA 957/4885MAOB 1244/4885CDC25B 2775/4885
US-20020119992-A1 Thrombin inhibitors SERPINC1, F2, TFPI MAOA 3009/4885MAOB 2230/4885CDC25B 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.